Potential Peripartum Markers of Infectious-Inflammatory Complications in Spontaneous Preterm Birth

Table 1

List of protein candidates for verification.

	Unused^b	Access. #	Name	Peptides; (95%)^c	iTRAQ; 115 : 114^d	iTRAQ; 115 : 114^e	iTRAQ; 117 : 116^d	iTRAQ; 117 : 116^e	AVG; change^f
318	11.71	P0CG48	Polyubiquitin-C
374	10.00	P09228	Cystatin-SA
154	27.52	P31025	Lipocalin-1
110	35.41	P03973	Antileukoproteinase
438	7.70	P59666	Neutrophil defensin 3
225	17.96	P09466	Glycodelin
73	44.36	P00915	Carbonic anhydrase 1
167	25.81	P07358	Complement component C8 beta chain
8	175.57	P02452	Collagen alpha-1(I) chain
115	34.38	P60174	Triosephosphate isomerase
37	73.59	P60709	Actin, cytoplasmic 1
228	17.59	P43490	Nicotinamide phosphoribosyltransferase
16	113.54	Q9HC84	Mucin-5B
385	9.51	Q9BRK3	Matrix-remodeling-associated protein 8
238	16.30	P20930	Filaggrin
237	16.31	P14384	Carboxypeptidase M

Protein rank relative to all other proteins identified in the exploratory analysis.
^bProteinPilot protein score.
^cNumber of iTRAQ peptides used for quantification of the protein.
^dAverage protein iTRAQ ratios (MIAC and HCA positive versus MIAC and HCA negative).
^eSignificance level for protein iTRAQ ratios.
^fExtremity of the iTRAQ change calculated as the absolute log₂ of the average iTRAQ ratio.